PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | -99.2% | 150 | -99.1% | 0.00% | – |
| Q2 2023 | $51,935 | +4.6% | 16,214 | -4.3% | 0.00% | – |
| Q1 2023 | $49,666 | -32.9% | 16,941 | -2.8% | 0.00% | – |
| Q4 2022 | $74,000 | +76.2% | 17,430 | -0.3% | 0.00% | – |
| Q3 2022 | $42,000 | 0.0% | 17,482 | +16.7% | 0.00% | – |
| Q2 2022 | $42,000 | +27.3% | 14,980 | -1.8% | 0.00% | – |
| Q1 2022 | $33,000 | -32.7% | 15,260 | -2.0% | 0.00% | – |
| Q4 2021 | $49,000 | -75.0% | 15,571 | -46.7% | 0.00% | – |
| Q3 2021 | $196,000 | +46.3% | 29,219 | +100.4% | 0.00% | – |
| Q2 2021 | $134,000 | +5.5% | 14,577 | +11.6% | 0.00% | – |
| Q1 2021 | $127,000 | +2.4% | 13,060 | +7.6% | 0.00% | – |
| Q4 2020 | $124,000 | -15.6% | 12,140 | -16.3% | 0.00% | – |
| Q3 2020 | $147,000 | +36.1% | 14,510 | +40.1% | 0.00% | – |
| Q2 2020 | $108,000 | +35.0% | 10,355 | +8.5% | 0.00% | – |
| Q1 2020 | $80,000 | – | 9,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |